A detailed history of N.E.W. Advisory Services LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, N.E.W. Advisory Services LLC holds 5,285 shares of MRK stock, worth $514,970. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,285
Previous 4,948 6.81%
Holding current value
$514,970
Previous $612,000 1.96%
% of portfolio
0.06%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$111.15 - $128.97 $37,457 - $43,462
337 Added 6.81%
5,285 $600,000
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $8,913 - $9,573
72 Added 1.48%
4,948 $612,000
Q1 2024

Apr 24, 2024

BUY
$113.24 - $131.95 $124,450 - $145,013
1,099 Added 29.1%
4,876 $643,000
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $32,758 - $35,649
-327 Reduced 7.97%
3,777 $411,000
Q3 2023

Nov 03, 2023

SELL
$102.95 - $114.33 $39,841 - $44,245
-387 Reduced 8.62%
4,104 $422,000
Q2 2023

Aug 04, 2023

SELL
$108.61 - $118.38 $9,123 - $9,943
-84 Reduced 1.84%
4,491 $518,000
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $25,529 - $28,485
248 Added 5.73%
4,575 $486,000
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $6,295 - $8,071
-72 Reduced 1.64%
4,327 $479,000
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $6,593 - $7,406
-78 Reduced 1.74%
4,399 $379,000
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $373,784 - $423,703
4,477 New
4,477 $408,000
Q1 2022

Apr 11, 2022

SELL
$73.51 - $82.4 $323,958 - $363,136
-4,407 Closed
0 $0
Q4 2021

Jan 18, 2022

BUY
$72.28 - $90.54 $86,591 - $108,466
1,198 Added 37.33%
4,407 $338,000
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $42,792 - $47,061
597 Added 22.86%
3,209 $241,000
Q2 2021

Jul 15, 2021

BUY
$70.31 - $77.77 $183,649 - $203,135
2,612 New
2,612 $204,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track N.E.W. Advisory Services LLC Portfolio

Follow N.E.W. Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N.E.W. Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on N.E.W. Advisory Services LLC with notifications on news.